Difficulty: Medium
Average Score: 69%
Practice
A 67-year-old chronic smoker with COPD and chronic heart failure presents to his primary care physician for follow-up. The patient takes multiple medications for these problems. Which of the following strategies may prove to have additional benefit in the treatment of this patient?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Stopping use of nonsteroidal anti-inflammatory agents. This is because NSAIDs can cause sodium and water retention, exacerbating heart failure symptoms in a patient with chronic heart failure. Additionally, NSAIDs can increase blood pressure and interfere with the effects of certain cardiovascular medications, making them detrimental in this case.
Option A, an exercise program involving alternating running and walking, may not be suitable for a 67-year-old patient with COPD and chronic heart failure due to the potential strain on the cardiovascular system and respiratory compromise.
Option B suggests increasing sodium intake to 2,000 mg/d, which goes against the standard dietary recommendations for heart failure patients who are advised to limit sodium intake to prevent fluid retention and worsening of heart failure symptoms.
Option D proposes the use of ß-blockers at high doses. While ß-blockers are commonly used in heart failure management, starting at high doses in a patient with COPD can potentially exacerbate respiratory issues due to their effect on bronchial smooth muscle.
This educational context highlights the importance of understanding the pharmacological interactions and considerations in managing complex patients with multiple comorbidities, emphasizing the need for individualized treatment plans based on the patient's specific conditions and medication profiles.
Option A, an exercise program involving alternating running and walking, may not be suitable for a 67-year-old patient with COPD and chronic heart failure due to the potential strain on the cardiovascular system and respiratory compromise.
Option B suggests increasing sodium intake to 2,000 mg/d, which goes against the standard dietary recommendations for heart failure patients who are advised to limit sodium intake to prevent fluid retention and worsening of heart failure symptoms.
Option D proposes the use of ß-blockers at high doses. While ß-blockers are commonly used in heart failure management, starting at high doses in a patient with COPD can potentially exacerbate respiratory issues due to their effect on bronchial smooth muscle.
This educational context highlights the importance of understanding the pharmacological interactions and considerations in managing complex patients with multiple comorbidities, emphasizing the need for individualized treatment plans based on the patient's specific conditions and medication profiles.